Alder Biopharmaceuticals Inc. Rises From Ashes of Layoffs, Overcomes Skeptics to Become Seattle Biotech Force

Bookmark and Share

Xconomy.com -- Nobody would have guessed the seeds for one of Seattle’s most promising biotech companies were being planted just before Thanksgiving in 2003. That’s when Randy Schatzman had the depressing task of firing all 90 people who worked for him, and closing the doors at Celltech R&D in Bothell, WA.

MORE ON THIS TOPIC